life-threatening Tagged Articles

Dialysis solutions recalled due to potential contamination

Posted: August 18, 2014 Recalls

Baxter International is recalling two lots of Dianeal Low Calcium Peritoneal Dialysis Solution with 2.5 percent Dextrose 5000mL (Ambu-Flex II) because oxidized stainless steel, garment fiber and PVC particulate matter was present during the manufacturing process and seen floating in

Injectable skin and blood infection treatment recalled

Posted: August 9, 2014 Recalls

Certain lots of the injectable drug Cubicin (daptomycin), used to treat skin infections and certain blood stream infections, are being recalled because of the potential presence of glass particles in vials. The administration of glass particulate, if present in an

Pre-diabetes diagnoses benefit drug companies more than patients

Posted: July 20, 2014 Pharmaceutical

Non-diabetics with higher-than-recommended blood sugar levels and thus at risk for developing type 2 diabetes are considered pre-diabetic, however classifying large numbers of people with pre-diabetes offers more benefit to drug companies than those diagnosed with the condition, researchers argue.

Hospira recalls intravenous fluid replacement due to mold contamination

Posted: July 12, 2014 Recalls

Hospira Inc. is issuing a nationwide recall of one lot of Lactated Ringers and 5 % Dextrose Injection because a bag of the intravenous fluid replacement was found to be contaminated with mold.

Testosterone therapy prescribed generously despite potentially dangerous side effects

Posted: July 10, 2014 Pharmaceutical

The number of prescriptions for testosterone replacement therapy for men 40 years of age and older has risen 300 percent between 2001 and 2011, and a quarter of the most recent testosterone therapy users have never had their blood levels

MBL granted A-Rod therapeutic use exemption for testosterone therapy

Posted: July 7, 2014 Pharmaceutical

Yankees third baseman Alex Rodriguez, best known as A-Rod, was using a testosterone treatment during the 2007 season under a therapeutic use exemption from Major League Baseball, according to a new book titled Blood Sport: Alex Rodriguez, Biogenesis and the

Antidepressant use during pregnancy remains controversial issue

Posted: June 23, 2014 Pharmaceutical

A new study suggesting that there is no increased risk of heart defects in newborns exposed to antidepressants in the first three months of gestation is being criticized by medical experts.

Drug to treat rare disorders recalled for third time since August

Posted: June 4, 2014 Recalls

Alexion Pharmaceuticals has issued the third recall since August of its sole approved drug Soliris after visible particles were seen in some vials during periodic testing. If injected, the particles could pose safety risks to patients in two general areas

Statins fail to offer benefit to patients with serious lung diseases

Posted: May 31, 2014 Pharmaceutical

Studies using statin medication to treat patients with chronic obstructive pulmonary disease (COPD) or acute respiratory distress syndrome (ARDS) failed to show any respiratory benefit to patients and as a result were halted early. The research was conducted after observational

Skin reaction warning added to Excedrin Migraine over-the-counter pain reliever

Posted: May 22, 2014 Pharmaceutical

Safety labels of over-the-counter pain reliever Excedrin Migraine have been updated to include a warning for serious skin reactions, the Food and Drug Administration (FDA) announced. Symptoms of this allergic reaction include skin reddening, blisters and rash. Consumers who use